Atlas Trials

EGFR-TKI Combined With Concurrent or Sequential Chemotherapy for Patients of Gradual Progression

Clinical trial NCT03544814 · COMPLETED

Trial details

NCT number
NCT03544814
Sponsor
Shanghai Chest Hospital
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Lung AdenocarcinomaEGFR Activating Mutation
Start date
2015-01-01
Primary completion
2017-06-01
Enrollment
99

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.